Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study

Background: With the increasing disease burden of cancer worldwide, more and more anticancer drugs have been approved in many countries, and the results of budget impact analyses (BIAs) have become important evidence for related reimbursement decisions. Objectives: We systematically reviewed whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yue, Li, Yuxin, Ma, Aixia, Li, Hongchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602071/
https://www.ncbi.nlm.nih.gov/pubmed/34805082
http://dx.doi.org/10.3389/fpubh.2021.777199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602071/
https://www.ncbi.nlm.nih.gov/pubmed/34805082
http://dx.doi.org/10.3389/fpubh.2021.777199

Ejemplares similares